Biological E manufactured J&J’s One Shot Vaccine to Hit The Market Soon

The single Vaccine shot of US’s pharma giant Johnson & Johnson manufactured by Biological E is expected to hit the market by next month. The will be rolled out in the market in October according to reports.The of the J&J was approved by the drug regulator, Drug Controller General of India (DCGI) to use it in India. This single shot Vaccine is the fifth that has received Emergency Use Approval (EUA).

Experts in the US and all over the world hade were expecting that the covid-19 cases will come to an end as the vaccination rates had picked up and death toll was consistently coming down. But, the situation seems to be exactly opposite. This is due to the resurgence of covid-19 cases leading to dying hopes of being free of covid-19.

The new variant of covid-19 virus called delta variant is overflowing hospital beds due to alarming increase of infections in children and adults. Some places have seen driving deaths due to the variant.

With regards to this the Vaccine rollouts have picked up to meet the rising demands of people for getting vaccinated.This new single shot Vaccine has shown 85% efficiency in preventing the severe disease that will is truly believed to bring down the infection rates across regions.Johnson & Johnson is confident that the Vaccine will protect people against hospitalizations and death. It will show effectiveness in fighting the covid-19 after 28 days of vaccination.